Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 15851-15900 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT03991377
A Rater-blinded RCT to Compare Effectiveness of EMDR vs TAU in Patients With First Episode Psychosis and History of Psychological Trauma
NA
Active, not recruiting
71 participants
Started: Apr 25, 2019 · Completed: Dec 31, 2024
2 conditions
4 sponsors
1 location
NCT04549220
Serosurveillance Study of Maternally Derived Anti-GBS Antibody
N/A
Active, not recruiting
6,000 participants
Started: Apr 24, 2019 · Completed: Jul 30, 2025
5 conditions
3 sponsors
1 location
NCT03920410
Effect of Serotonergic Stimulation on the Gut-brain Axis
NA
Active, not recruiting
58 participants
Started: Apr 24, 2019 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT03929718
Efficacy of Aldosterone Antagonist Therapy for Prevention of New Atrial Fibrillation
EARLY_PHASE1
Active, not recruiting
50 participants
Started: Apr 24, 2019 · Completed: Sep 30, 2027
1 condition
1 sponsor
1 location
NCT03899220
Project Matter: Intervention to Improve HIV Self-care Among Men Who Have Sex With Men (MSM) With Substance Use Disorders
NA
Active, not recruiting
50 participants
Started: Apr 24, 2019 · Completed: Jan 31, 2025
3 conditions
2 sponsors
1 location
NCT03918915
The Safety and Efficacy of SYD-101 in Children With Myopia
PHASE3
Active, not recruiting
852 participants
Started: Apr 24, 2019 · Completed: May 31, 2025
3 conditions
1 sponsor
47 locations
NCT03927079
Predictive Factors of Good Pulmonary Penetration of Antibiotics : AntiBiotics Dosage in Broncho-Alveolar Lavage
NA
Active, not recruiting
101 participants
Started: Apr 23, 2019 · Completed: Jun 1, 2026
2 conditions
1 sponsor
1 location
NCT03913299
Frailty Assessment by Edmonton Frail Scale to Predict Outcome in Patients Undergoing Cardiovascular Surgery
N/A
Active, not recruiting
2,080 participants
Started: Apr 23, 2019 · Completed: Sep 30, 2026
3 conditions
1 sponsor
3 locations
NCT03104517
Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence
PHASE3
Active, not recruiting
96 participants
Started: Apr 23, 2019 · Completed: Sep 30, 2027
1 condition
1 sponsor
21 locations
NCT05412537
The Impact of Motivation in Return to Work After Work Disability
NA
Active, not recruiting
272 participants
Started: Apr 23, 2019 · Completed: Dec 27, 2025
4 conditions
2 sponsors
1 location
NCT03884543
Driving Pressure During General Anesthesia for Open Abdominal Surgery
NA
Active, not recruiting
1,468 participants
Started: Apr 23, 2019 · Completed: Jun 30, 2025
1 condition
33 sponsors
22 locations
NCT04310826
Dietary Magnesium in Preventing Low Blood Magnesium Levels in Patients With Ovarian Cancer Receiving Carboplatin Chemotherapy
NA
Active, not recruiting
26 participants
Started: Apr 23, 2019 · Completed: Apr 1, 2026
1 condition
2 sponsors
1 location
NCT03635632
C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)
PHASE1
Active, not recruiting
94 participants
Started: Apr 23, 2019 · Completed: May 16, 2038
7 conditions
4 sponsors
2 locations
NCT03581136
Phase II Multi-center Trial Evaluating 5 Fraction Stereotactic Partial Breast Irradiation Using Gammapod
NA
Active, not recruiting
74 participants
Started: Apr 22, 2019 · Completed: Jun 28, 2030
1 condition
1 sponsor
2 locations
NCT03684447
Neural and Antidepressant Effects of Propofol
PHASE2/PHASE3
Active, not recruiting
48 participants
Started: Apr 21, 2019 · Completed: Jul 31, 2024
1 condition
1 sponsor
1 location
NCT03965611
Evolution of Oropharyngeal and Rectal Microbiota After Severe Traumatic Brain Injury
N/A
Active, not recruiting
58 participants
Started: Apr 21, 2019 · Completed: Dec 31, 2024
2 conditions
2 sponsors
1 location
NCT04271943
THE EFFECT OF AEROBIC AND GAME BASED EXERCISES ON COGNITIVE FUNCTIONS IN DEMENTIA
NA
Active, not recruiting
30 participants
Started: Apr 20, 2019 · Completed: Jan 31, 2025
1 condition
1 sponsor
1 location
NCT04135456
The Optimal Dose of Mannitol for Intraoperative Brain Relaxation During the Operation of Aneurysmal Subarachnoid Hemorrhage
PHASE1/PHASE2
Active, not recruiting
99 participants
Started: Apr 20, 2019 · Completed: Jan 14, 2024
1 condition
1 sponsor
1 location
NCT04042922
High Frequency Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease
NA
Active, not recruiting
80 participants
Started: Apr 19, 2019 · Completed: Apr 30, 2027
1 condition
1 sponsor
1 location
NCT03674047
Ruxolitinib for Bronchiolitis Obliterans Syndrome (BOS) After Allogeneic Hematopoietic Cell Transplantation (HCT)
PHASE2
Active, not recruiting
50 participants
Started: Apr 19, 2019 · Completed: Aug 31, 2025
1 condition
2 sponsors
7 locations
NCT03912207
Investigating Immune Responses to Aerosol BCG Challenge in Healthy UK Adults
PHASE1
Active, not recruiting
94 participants
Started: Apr 19, 2019 · Completed: Jun 30, 2024
1 condition
4 sponsors
2 locations
NCT03922035
CBM588 in Improving Clinical Outcomes in Patients Who Have Undergone Donor Hematopoietic Stem Cell Transplant
PHASE1
Active, not recruiting
36 participants
Started: Apr 18, 2019 · Completed: Mar 4, 2026
1 condition
2 sponsors
1 location
NCT03903120
ASSIST: Treatment for Childhood Apraxia of Speech
PHASE1
Active, not recruiting
420 participants
Started: Apr 18, 2019 · Completed: Mar 31, 2025
1 condition
1 sponsor
1 location
NCT04082689
Bowel And Bladder Function in Infant Toilet Training
NA
Active, not recruiting
293 participants
Started: Apr 18, 2019 · Completed: Sep 30, 2025
4 conditions
4 sponsors
6 locations
NCT03974893
Dietary Intake, Sarcopenic Obesity, and Other Treatment-Related Outcomes in Indian Children With Acute Lymphoblastic Leukemia
N/A
Active, not recruiting
115 participants
Started: Apr 18, 2019 · Completed: Oct 31, 2025
1 condition
2 sponsors
1 location
NCT03964532
TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer
PHASE1/PHASE2
Active, not recruiting
24 participants
Started: Apr 17, 2019 · Completed: Mar 31, 2026
1 condition
2 sponsors
2 locations
NCT03910387
Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer
PHASE2
Active, not recruiting
22 participants
Started: Apr 17, 2019 · Completed: Oct 1, 2024
5 conditions
3 sponsors
3 locations
NCT03806608
Evaluation of MBL Around Implants Placed in Crestal or Subcrestal Positions: a RCT
NA
Active, not recruiting
20 participants
Started: Apr 17, 2019 · Completed: May 31, 2026
2 conditions
1 sponsor
1 location
NCT03918070
Observatory to Assess the Yukon Choice PC & the Yukon Chrome PC Sirolimus Eluting Bioabsorbable Polymer Stents Systems
N/A
Active, not recruiting
2,722 participants
Started: Apr 17, 2019 · Completed: May 24, 2024
1 condition
2 sponsors
19 locations
NCT03911973
Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers
PHASE1/PHASE2
Active, not recruiting
37 participants
Started: Apr 17, 2019 · Completed: Jul 31, 2024
1 condition
3 sponsors
5 locations
NCT03709446
Leflunomide in Previously Treated Metastatic Triple Negative Cancers
PHASE1/PHASE2
Active, not recruiting
17 participants
Started: Apr 16, 2019 · Completed: Nov 30, 2025
3 conditions
1 sponsor
3 locations
NCT03930576
Consequences of Unwanted Pregnancy in Nepal
N/A
Active, not recruiting
1,436 participants
Started: Apr 16, 2019 · Completed: Dec 15, 2028
1 condition
2 sponsors
1 location
NCT03651128
Efficacy and Safety Study of bb2121 Versus Standard Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)
PHASE3
Active, not recruiting
381 participants
Started: Apr 16, 2019 · Completed: Apr 8, 2027
1 condition
1 sponsor
60 locations
NCT03896737
Daratumumab-bortezomib-dexamethasone (Dara-VCd) vs Bortezomib-Thalidomide-Dexamethasone (VTd), Then Maintenance With Ixazomib (IXA) or IXA-Dara
PHASE2
Active, not recruiting
401 participants
Started: Apr 16, 2019 · Completed: Feb 1, 2028
1 condition
2 sponsors
3 locations
NCT03875235
Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1)
PHASE3
Active, not recruiting
810 participants
Started: Apr 16, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
126 locations
NCT03930056
C-Brace II Spinal Cord Injury
NA
Active, not recruiting
30 participants
Started: Apr 16, 2019 · Completed: Nov 30, 2025
1 condition
2 sponsors
1 location
NCT06153641
Cytokeratin 18 Non-invasive Biomarker for Rejection in Liver Transplant Patients
N/A
Active, not recruiting
70 participants
Started: Apr 16, 2019 · Completed: Sep 24, 2025
2 conditions
2 sponsors
1 location
NCT03624595
Low-dose Dexmedetomidine and Postoperative Delirium After Cardiac Surgery
NA
Active, not recruiting
502 participants
Started: Apr 16, 2019 · Completed: Aug 31, 2025
5 conditions
2 sponsors
2 locations
NCT03731260
(PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, Versus Placebo in Patients With Indolent Systemic Mastocytosis
PHASE2
Active, not recruiting
251 participants
Started: Apr 16, 2019 · Completed: Jun 23, 2027
1 condition
1 sponsor
49 locations
NCT03907852
Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer
PHASE1/PHASE2
Active, not recruiting
57 participants
Started: Apr 15, 2019 · Completed: Nov 2, 2028
11 conditions
2 sponsors
11 locations
NCT03809000
A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery
PHASE2
Active, not recruiting
188 participants
Started: Apr 15, 2019 · Completed: Sep 15, 2029
1 condition
3 sponsors
108 locations
NCT03892824
Carotid Artery Implant for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants
NA
Active, not recruiting
100 participants
Started: Apr 15, 2019 · Completed: Oct 24, 2027
2 conditions
2 sponsors
17 locations
NCT04031989
Repository of Phase Signals for Pulmonary Hypertension Algorithm Development
NA
Active, not recruiting
2,500 participants
Started: Apr 15, 2019 · Completed: Aug 31, 2024
3 conditions
1 sponsor
17 locations
NCT03858153
Exercise and Nutrition Interventions During Chemotherapy K07
PHASE2
Active, not recruiting
80 participants
Started: Apr 15, 2019 · Completed: Dec 31, 2025
1 condition
2 sponsors
2 locations
NCT03668223
The PRISM Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults With Advanced Cancer
NA
Active, not recruiting
195 participants
Started: Apr 15, 2019 · Completed: Oct 31, 2025
7 conditions
6 sponsors
5 locations
NCT03913481
Acute Normovolemic Hemodilution in High Risk Cardiac Surgery Patients.
NA
Active, not recruiting
2,000 participants
Started: Apr 15, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
32 locations
NCT04180241
Development of Endoscopic Treatment for Achalasia
NA
Active, not recruiting
55 participants
Started: Apr 15, 2019 · Completed: Dec 31, 2027
1 condition
1 sponsor
2 locations
NCT04065984
Body Composition Manipulation in CoLorectal cancEr (BiCyCLE): Neuromuscular Electrical Stimulation (NMES)
NA
Active, not recruiting
46 participants
Started: Apr 14, 2019 · Completed: Mar 1, 2026
8 conditions
1 sponsor
1 location
NCT03085004
CHARM II: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts
PHASE3
Active, not recruiting
75 participants
Started: Apr 12, 2019 · Completed: Feb 1, 2026
2 conditions
2 sponsors
2 locations
NCT03825796
CPX-351 Plus Enasidenib for Relapsed AML
PHASE2
Active, not recruiting
2 participants
Started: Apr 12, 2019 · Completed: Sep 1, 2024
1 condition
2 sponsors
3 locations
Previous
1
More pages
315
316
317
318
319
320
321
More pages
431
Next